These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16797494)

  • 1. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
    Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats.
    Fukuda H; Chen C; Mantyh C; Ludwig K; Pappas TN; Takahashi T
    J Surg Res; 2006 Apr; 131(2):290-5. PubMed ID: 16259999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Neyens R; Jackson KC
    J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
    Saclarides TJ
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW
    Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus.
    Schmidt J; Stoffels B; Nazir A; Dehaven-Hudkins DL; Bauer AJ
    Neurogastroenterol Motil; 2008 Jun; 20(6):689-99. PubMed ID: 18266613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract.
    Fukuda H; Tsuchida D; Koda K; Miyazaki M; Pappas TN; Takahashi T
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1293-9. PubMed ID: 17688668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging pharmacologic options for treating postoperative ileus.
    Kraft MD
    Am J Health Syst Pharm; 2007 Oct; 64(20 Suppl 13):S13-20. PubMed ID: 17909271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
    Kraft MD
    Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alvimopan for the management of postoperative ileus.
    Leslie JB
    Ann Pharmacother; 2005 Sep; 39(9):1502-10. PubMed ID: 16076918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond.
    Sinatra RS
    J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S16-23. PubMed ID: 16597531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.
    Schmidt WK
    Am J Surg; 2001 Nov; 182(5A Suppl):27S-38S. PubMed ID: 11755894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Becker G; Blum HE
    Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
    Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
    Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
    Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
    Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor.
    DeHaven-Hudkins DL; DeHaven RN; Little PJ; Techner LM
    Pharmacol Ther; 2008 Jan; 117(1):162-87. PubMed ID: 18022696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.
    Viscusi ER; Goldstein S; Witkowski T; Andonakakis A; Jan R; Gabriel K; Du W; Techner L; Wallin B
    Surg Endosc; 2006 Jan; 20(1):64-70. PubMed ID: 16333556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alvimopan, a selective peripherally acting mu-opioid antagonist.
    Camilleri M
    Neurogastroenterol Motil; 2005 Apr; 17(2):157-65. PubMed ID: 15787936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
    Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
    Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study.
    Büchler MW; Seiler CM; Monson JR; Flamant Y; Thompson-Fawcett MW; Byrne MM; Mortensen ER; Altman JF; Williamson R
    Aliment Pharmacol Ther; 2008 Aug; 28(3):312-25. PubMed ID: 19086236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.